Skip to main content
. 2014 Dec 9;14(2):441–454. doi: 10.1074/mcp.M114.040790

Table III. Peak Area Ratio-to-Heavy Values in Sample Matrices of Varying Content Concentration and Complexity.

Peptide No-Matrix
0.001 μg E.coli background
0.01 μg E.coli background
0.1 μg E.coli background
0.1 μg Phospholipid-depleted Plasma background
0.1 μg Plasma background
Per Peptide
Peak Area Ratio to Heavy Precision (%CV) Peak Area Ratio to Heavy Precision (%CV) Peak Area Ratio to Heavy Precision (%CV) Peak Area Ratio to Heavy Precision (%CV) Peak Area Ratio to Heavy Precision (%CV) Peak Area Ratio to Heavy Precision (%CV) p-Valueb
HHGPTITAKPTITAK 0.85 3.29 0.30 9.88 0.28 8.00 0.29 5.37 0.33 6.01 0.29 4.02 <0.01
NLPSDSQDLGQHGLEED 1.43 3.65 0.91 5.55 0.99 2.19 0.89 9.85 0.95 10.11 0.96 7.97 <0.01
VNSQSLSPYLFR 1.11 2.67 0.51 5.97 0.50 5.21 0.49 6.03 0.53 4.75 0.55 5.51 <0.01
VSAQQVQGVHAR 1.80 5.70 1.31 11.45 1.56 7.98 1.38 2.31 1.50 9.80 1.53 8.88 <0.01
Matrix p-Valuea <0.01 0.20 0.01 0.87 <0.01 0.86 <0.01 0.33 <0.01 0.66

a Matrix p value refers to the combined comparison across matrices for all peptides by a Repeated Measures ANOVA. The p values stated are the pairwise comparisons against No-Matrix. There were no significant differences between matrices otherwise.

b The Per-peptide p value refers to the comparison of the replicate peak area ratio-heavy values across matrices for the individual peptide. Peak area ratio-to-heavy values for all peptides were significantly different when a biological matrix was introduced. Italics denotes p values of significant difference.